Doctors at the University of Pennsylvania are participating in a clinical research trial for an approved study drug looking at individuals living in an Assisted Living facility with mild to severe Alzheimer's disease. Qualified participants will receive study-related evaluations, lab work, electrocardiograms, and cognitive evaluations at no charge while taking part in the study.

Eligible participants must:

Be male or female age 50 years or older

Live in an Assisted Living facility

Be diagnosed with mild to severe Alzheimer's disease

Have a dedicated caregiver or informant

Be able to read, understand, and speak English

For more information, please contact Kate at 215-349-8227.